Market Summary
USD205.42-3.46
Market Closed-1.66%
IQV Stock Price
IQV RSI Chart
IQV Valuation
IQV Price/Sales (Trailing)
IQV Profitability
IQV Fundamentals
IQV Revenue
IQV Earnings
Price Action
52 Week Range
165.75241.86
(Low)(High)
Last 7 days
-3.6%
Last 30 days
-2.4%
Last 90 days
-2.3%
Trailing 12 Months
2.5%
IQV Financial Health
IQV Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for IQV
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-03 | Bruehlman Ronald E | sold (taxes) | -559,758 | 216 | -2,588 | see remarks |
2023-07-28 | Cherofsky Keriann | sold (taxes) | -7,915 | 226 | -35.00 | see remarks |
2023-06-05 | Knightly Kevin C | sold | -1,175,000 | 201 | -5,820 | see remarks |
2023-05-26 | Knightly Kevin C | sold | -198 | 198 | -1.00 | see remarks |
2023-05-10 | GOGGINS COLLEEN A | acquired | - | - | 1,063 | - |
2023-05-10 | Wims Morris Leslie | acquired | - | - | 1,063 | - |
2023-05-10 | Burt Carol | acquired | - | - | 1,063 | - |
2023-05-10 | Stamps Sheila A | acquired | - | - | 1,063 | - |
2023-05-10 | LEONARD JOHN M | acquired | - | - | 1,063 | - |
2023-05-10 | Fasano Jim | acquired | - | - | 1,063 | - |
Which funds bought or sold IQV recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | added | 47.5 | 5,316 | 13,349 | -% |
2023-09-07 | JAG CAPITAL MANAGEMENT, LLC | new | - | 2,447,520 | 2,447,520 | 0.28% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 33,041 | 33,041 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | reduced | -9.82 | 7,312 | 389,976 | 0.09% |
2023-08-24 | ProVise Management Group, LLC | reduced | -4.1 | 29,236 | 378,288 | 0.03% |
2023-08-24 | Alberta Investment Management Corp | added | 7.39 | 6,667,960 | 37,874,200 | 0.36% |
2023-08-23 | Stonebridge Capital Advisors LLC | added | 0.88 | 254,214 | 2,069,680 | 0.22% |
2023-08-22 | Old North State Trust, LLC | sold off | -100 | -27,000 | - | -% |
2023-08-22 | Asset Dedication, LLC | reduced | -13.51 | -1,000 | 14,000 | -% |
2023-08-22 | COMERICA BANK | new | - | 1,000 | 1,000 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Iqvia Holdings
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | vanguard group inc | 11.55% | 21,447,600 | SC 13G/A | |
| Feb 07, 2023 | blackrock inc. | 8.5% | 15,763,249 | SC 13G/A | |
| Feb 07, 2022 | blackrock inc. | 7.9% | 15,139,662 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 10.93% | 20,954,687 | SC 13G/A | |
| Jan 29, 2021 | blackrock inc. | 7.7% | 14,826,277 | SC 13G/A | |
| Feb 10, 2020 | vanguard group inc | 10.03% | 19,475,899 | SC 13G/A | |
| Feb 10, 2020 | vanguard group inc | 9.97% | 19,346,266 | SC 13G/A | |
| Feb 05, 2020 | blackrock inc. | 7.6% | 14,685,767 | SC 13G/A | |
| Oct 10, 2019 | vanguard group inc | 10.24% | 20,064,602 | SC 13G/A |
Recent SEC filings of Iqvia Holdings
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 19, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 07, 2023 | 4 | Insider Trading | |
| Aug 01, 2023 | 8-K | Current Report | |
| Aug 01, 2023 | 4 | Insider Trading | |
| Aug 01, 2023 | 10-Q | Quarterly Report |
Peers (Alternatives to Iqvia Holdings)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
IQV | 37.6B | 14.7B | -2.38% | 2.54% | 34.32 | 2.56 | 3.86% | -5.52% |
A | 33.0B | 7.0B | -5.82% | -14.08% | 29.09 | 4.71 | 5.03% | -14.68% |
ILMN | 21.9B | 4.5B | -15.96% | -29.31% | -5.22 | 4.9 | -4.92% | -21931.58% |
CRL | 10.7B | 4.2B | 4.84% | 4.34% | 22.1 | 2.56 | 13.29% | 9.18% |
| MID-CAP | ||||||||
MEDP | 7.8B | 1.7B | 2.42% | 64.86% | 28.97 | 4.65 | 30.05% | 28.37% |
SYNH | 4.4B | 5.4B | 0.75% | -16.37% | 62.28 | 0.82 | 0.01% | -74.39% |
ARWR | 2.9B | 256.2M | -3.64% | -20.61% | -15.97 | 11.29 | 2.51% | -17.66% |
NEO | 1.6B | 551.6M | -5.76% | 29.78% | -13.84 | 2.88 | 12.73% | 21.90% |
| SMALL-CAP | ||||||||
AVXL | 589.3M | - | -12.75% | -21.59% | -11.41 | 6.7K | - | -13.75% |
PGEN | 357.7M | 22.1M | -18.01% | -50.00% | 16.15 | 16.18 | 43.14% | 124.16% |
SRNE | 170.9M | 66.2M | -71.28% | -88.95% | -0.25 | 2.73 | 20.37% | -7.56% |
CDXS | 118.7M | 99.2M | 5.42% | -74.78% | -2.09 | 1.2 | -26.56% | -199.52% |
PSNL | 64.0M | 67.1M | -25.29% | -63.99% | -0.58 | 0.95 | -12.13% | -17.68% |
Iqvia Holdings News
Returns for IQV
Cumulative Returns on IQV
16.7%
10-Year Cumulative Returns
15.2%
7-Year Cumulative Returns
10.4%
5-Year Cumulative Returns
10.0%
3-Year Cumulative Returns
Risks for IQV
What is the probability of a big loss on IQV?
51.1%
Probability that Iqvia Holdings stock will be more than 20% underwater in next one year
35.4%
Probability that Iqvia Holdings stock will be more than 30% underwater in next one year.
18.5%
Probability that Iqvia Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does IQV drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Iqvia Holdings was unfortunately bought at previous high price.
Drawdowns
Financials for Iqvia Holdings
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 1.3% | 14,681 | 14,494 | 14,410 | 14,307 | 14,136 | 14,033 | 13,874 | 13,536 | 12,931 | 12,014 | 11,359 | 10,956 | 10,939 | 11,158 | 11,088 | 10,881 | 10,706 | 10,533 | 10,412 | 10,245 | 10,117 |
| S&GA Expenses | 0.0% | 2,095 | 2,096 | 2,071 | 2,030 | 2,011 | 2,010 | 1,964 | 1,913 | 1,875 | 1,824 | 1,789 | 1,782 | 1,717 | 1,722 | 1,734 | 1,693 | 1,727 | 1,715 | 1,716 | 1,742 | 1,707 |
| EBITDA | -100.0% | - | 2,924 | 2,909 | 2,877 | 2,862 | 2,829 | 2,767 | 2,679 | 2,499 | 2,231 | 2,076 | 1,955 | 1,916 | 2,011 | 2,001 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.20* | 0.20* | 0.20* | 0.20* | 0.20* | 0.20* | 0.20* | 0.19* | 0.19* | 0.18* | 0.18* | 0.18* | 0.18* | 0.18* | - | - | - | - | - | - |
| Interest Expenses | 15.9% | 546 | 471 | 416 | 378 | 362 | 362 | 375 | 387 | 395 | 409 | 416 | 423 | 437 | 443 | 447 | 444 | 435 | 428 | 414 | 405 | 393 |
| Earnings Before Taxes | 3.5% | 1,372 | 1,325 | 1,363 | 1,464 | 1,377 | 1,271 | 1,128 | 946 | 775 | 528 | 373 | 275 | 242 | 345 | 352 | 360 | 342 | 352 | 328 | 257 | 292 |
| EBT Margin | -100.0% | - | 0.09* | 0.09* | 0.10* | 0.10* | 0.09* | 0.08* | 0.07* | 0.06* | 0.04* | 0.03* | 0.03* | 0.02* | 0.03* | 0.03* | - | - | - | - | - | - |
| Net Income | 3.9% | 1,096 | 1,055 | 1,091 | 1,182 | 1,160 | 1,079 | 966 | 772 | 612 | 416 | 290 | 187 | 143 | 224 | 191 | 244 | 247 | 248 | 259 | 1,217 | 1,245 |
| Net Income Margin | -100.0% | - | 0.07* | 0.08* | 0.08* | 0.08* | 0.08* | 0.07* | 0.06* | 0.05* | 0.03* | 0.02* | 0.02* | 0.01* | 0.02* | 0.02* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 2,169 | 2,260 | 2,392 | 2,373 | 2,583 | 2,942 | 3,000 | 2,730 | 2,663 | 1,959 | 1,792 | 1,548 | 1,467 | 1,417 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 1.2% | 26,036 | 25,739 | 25,337 | 24,223 | 24,413 | 24,969 | 24,689 | 24,033 | 23,937 | 24,467 | 24,564 | 23,837 | 23,183 | 23,078 | 23,251 | 22,892 | 23,068 | 23,109 | 22,549 | 22,498 | 22,626 |
| Current Assets | 0.0% | 5,329 | 5,328 | 4,981 | 4,752 | 4,911 | 4,772 | 4,763 | 4,534 | 5,068 | 5,579 | 5,090 | 4,645 | 4,208 | 4,277 | 4,126 | 3,995 | 3,978 | 3,999 | 3,874 | 3,696 | 3,587 |
| Cash Equivalents | -7.5% | 1,382 | 1,494 | 1,216 | 1,274 | 1,428 | 1,387 | 1,366 | 1,470 | 1,807 | 2,305 | 1,814 | 1,464 | 1,109 | 927 | 837 | 863 | 938 | 936 | 891 | 827 | 879 |
| Net PPE | -1.9% | 510 | 520 | 532 | 507 | 529 | 531 | 497 | 485 | 470 | 472 | 482 | 452 | 444 | 445 | 458 | 451 | 458 | 437 | 434 | 417 | 415 |
| Goodwill | 1.2% | 14,178 | 14,015 | 13,921 | 13,177 | 13,104 | 13,532 | 13,301 | 13,124 | 12,551 | 12,415 | 12,654 | 12,363 | 12,133 | 11,989 | 12,159 | 11,919 | 11,937 | 11,857 | 11,800 | 11,794 | 11,844 |
| Liabilities | 2.4% | 20,288 | 19,807 | 19,572 | 18,876 | 19,061 | 19,050 | 18,647 | 18,204 | 18,177 | 18,230 | 18,284 | 17,730 | 17,331 | 17,276 | 16,988 | 16,498 | 16,287 | 16,244 | 15,595 | 15,038 | 15,012 |
| Current Liabilities | -1.7% | 6,543 | 6,657 | 5,578 | 5,253 | 5,104 | 5,157 | 5,241 | 4,847 | 4,819 | 4,868 | 4,558 | 4,139 | 3,843 | 3,907 | 3,945 | 3,576 | 3,495 | 3,502 | 3,534 | 3,380 | 3,166 |
| LT Debt, Current | 0.1% | 1,344 | 1,343 | 152 | 151 | 152 | 90.00 | 91.00 | 91.00 | 147 | 144 | 149 | 144 | 142 | 139 | 100 | 98.00 | 100 | 100 | 100 | 101 | 101 |
| LT Debt, Non Current | 5.1% | 12,433 | 11,833 | 12,595 | 12,243 | 12,615 | 12,547 | 12,034 | 12,081 | 12,140 | 12,092 | 12,384 | 12,195 | 11,965 | 11,894 | 11,545 | 11,444 | 11,299 | 11,187 | 10,907 | 10,518 | 10,627 |
| Shareholder's Equity | -3.1% | 5,748 | 5,932 | 5,765 | 5,347 | 5,352 | 5,919 | 6,042 | 5,829 | 5,760 | 6,237 | 6,280 | 6,107 | 5,852 | 5,802 | 6,263 | 6,394 | 6,781 | 6,865 | 6,954 | 7,460 | 7,614 |
| Retained Earnings | 8.2% | 3,920 | 3,623 | 3,334 | 3,107 | 2,824 | 2,568 | 2,243 | 1,925 | 1,664 | 1,489 | 1,277 | 1,158 | 1,057 | 1,080 | 998 | 982 | 925 | 865 | 807 | 726 | 665 |
| Shares Outstanding | -1.3% | 183 | 186 | 186 | 186 | 188 | 190 | 191 | 192 | 192 | 192 | 191 | 191 | 191 | 192 | 192 | 195 | 196 | 197 | 198 | 202 | 206 |
| Minority Interest | - | - | - | - | - | - | - | - | - | - | 284 | 279 | 261 | 261 | 260 | 260 | 263 | 258 | 250 | 240 | 245 | 250 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 3.4% | 2,242 | 2,169 | 2,260 | 2,392 | 2,373 | 2,583 | 2,942 | 3,000 | 2,730 | 2,663 | 1,959 | 1,792 | 1,548 | 1,467 | 1,417 | 1,251 | 1,265 | 1,185 | 1,254 | 1,070 | 1,162 |
| Share Based Compensation | 2.1% | 244 | 239 | 194 | 178 | 165 | 168 | 170 | 154 | 139 | 127 | 95.00 | 128 | 122 | 120 | 146 | 122 | 126 | 118 | 113 | 102 | 100 |
| Cashflow From Investing | -24.6% | -2,012 | -1,615 | -2,006 | -2,176 | -2,554 | -2,540 | -2,103 | -1,692 | -788 | -822 | -796 | -840 | -1,049 | -1,025 | -1,190 | -1,088 | -870 | -1,005 | -810 | -1,048 | -1,200 |
| Cashflow From Financing | 32.1% | -262 | -386 | -329 | -274 | -89.00 | -923 | -1,235 | -1,295 | -1,282 | -492 | -217 | -362 | -270 | -397 | -276 | -91.00 | -331 | -183 | -452 | -249 | 45.00 |
| Buy Backs | 0% | 894 | 894 | 1,168 | 1,307 | 1,192 | 747 | 406 | 303 | 208 | 164 | 447 | 616 | 914 | 1,149 | 949 | 1,283 | 1,118 | 1,455 | 1,405 | 1,169 | 1,594 |
IQV Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenues | $ 3,728 | $ 3,541 | $ 7,380 | $ 7,109 |
| Cost of revenues, exclusive of depreciation and amortization | 2,443 | 2,331 | 4,841 | 4,654 |
| Selling, general and administrative expenses | 482 | 483 | 995 | 971 |
| Depreciation and amortization | 259 | 270 | 512 | 525 |
| Restructuring costs | 20 | 4 | 37 | 11 |
| Income from operations | 524 | 453 | 995 | 948 |
| Interest income | (4) | (2) | (10) | (3) |
| Interest expense | 169 | 94 | 310 | 180 |
| Other (income) expense, net | (16) | 33 | (42) | 43 |
| Income before income taxes and equity in earnings (losses) of unconsolidated affiliates | 375 | 328 | 737 | 728 |
| Income tax expense | 81 | 71 | 152 | 142 |
| Income before equity in earnings (losses) of unconsolidated affiliates | 294 | 257 | 585 | 586 |
| Equity in earnings (losses) of unconsolidated affiliates | 3 | (1) | 1 | (5) |
| Net income | 297 | 256 | 586 | 581 |
| Net Income (Loss) Attributable to Parent, Total | $ 297 | $ 256 | $ 586 | $ 581 |
| Earnings per share attributable to common stockholders: | ||||
| Basic (in dollars per share) | $ 1.61 | $ 1.36 | $ 3.17 | $ 3.07 |
| Diluted (in dollars per share) | $ 1.59 | $ 1.34 | $ 3.12 | $ 3.02 |
| Weighted average common shares outstanding: | ||||
| Basic (in shares) | 184.4 | 188.3 | 185.1 | 189.2 |
| Diluted (in shares) | 186.7 | 191.1 | 187.6 | 192.2 |
IQV Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 1,382 | $ 1,216 |
| Trade accounts receivable and unbilled services, net | 3,139 | 2,917 |
| Prepaid expenses | 179 | 151 |
| Income taxes receivable | 45 | 43 |
| Investments in debt, equity and other securities | 110 | 93 |
| Other current assets and receivables | 474 | 561 |
| Total current assets | 5,329 | 4,981 |
| Property and equipment, net | 510 | 532 |
| Operating lease right-of-use assets | 319 | 331 |
| Investments in debt, equity and other securities | 101 | 68 |
| Investments in unconsolidated affiliates | 107 | 94 |
| Goodwill | 14,178 | 13,921 |
| Other identifiable intangibles, net | 4,942 | 4,820 |
| Deferred income taxes | 115 | 118 |
| Deposits and other assets, net | 435 | 472 |
| Total assets | 26,036 | 25,337 |
| Current liabilities: | ||
| Accounts payable and accrued expenses | 3,007 | 3,316 |
| Unearned income | 1,844 | 1,797 |
| Income taxes payable | 208 | 161 |
| Current portion of long-term debt | 1,344 | 152 |
| Other current liabilities | 140 | 152 |
| Total current liabilities | 6,543 | 5,578 |
| Long-term debt, less current portion | 12,433 | 12,595 |
| Deferred income taxes | 367 | 464 |
| Operating lease liabilities | 242 | 264 |
| Other liabilities | 703 | 671 |
| Total liabilities | 20,288 | 19,572 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Common stock and additional paid-in capital, 400.0 shares authorized as of June 30, 2023 and December 31, 2022, $0.01 par value, 257.0 shares issued and 183.1 shares outstanding as of June 30, 2023; 256.4 shares issued and 185.7 shares outstanding as of December 31, 2022 | 10,952 | 10,898 |
| Retained earnings | 3,920 | 3,334 |
| Treasury stock, at cost, 73.9 and 70.7 shares as of June 30, 2023 and December 31, 2022, respectively | (8,364) | (7,740) |
| Accumulated other comprehensive loss | (760) | (727) |
| Total stockholders’ equity | 5,748 | 5,765 |
| Total liabilities and stockholders’ equity | $ 26,036 | $ 25,337 |
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.